Active Heart, Stroke & Blood

Cell surface glycocalyx control of immune cell recruitment and pathology in the inflamed brain

In plain English

AI plain-English summary

A sugary coating on blood vessels and immune cells controls whether inflammatory cells can enter the brain—and a new project will test whether manipulating this coating can limit damage after a stroke. This matters because the brain cannot regenerate its neurons, so every inflammatory immune cell that crosses into brain tissue risks causing permanent harm. Chemokines—the molecules that guide immune cells—have long been suspected as drivers of brain inflammation, but drugs targeting them have failed, partly because scientists did not understand how the glycocalyx, a gel-like layer on cell surfaces, physically regulates their activity. The research uses stroke, the second leading cause of death and disability worldwide, as a model to study this overlooked structure. If successful, the work could reveal why existing chemokine-targeting therapies have not worked and point toward new ways to block damaging immune cell entry into the brain after stroke or other inflammatory conditions. This is fundamental science: it aims to transform understanding of a basic mechanism of cell trafficking, not to produce an immediate treatment. Similar fundamental insights into how cells move through tissues have previously led to therapies for autoimmune diseases and cancer immunotherapy.

View original technical description
There is exquisite control of immune cell recruitment to all bodily tissues. In injury and disease, such control is important to appropriately resolve the insult or infection whilst limiting inflammation that can drive pathology. In the brain, this takes on critical significance, as central nervous system neurons do not regenerate, therefore limiting damage by infiltrating inflammatory immune cells is crucial to retain function. Chemokines are molecules that mediate immune cell recruitment, and are heavily implicated in pathological brain inflammation, but have not been successfully therapeutically targeted during inflammation due to limited understanding of their basic biology. My lab has produced published and preliminary data demonstrating that an under-appreciated structure, the glycocalyx, on endothelial- and immune- cells regulates chemokine mediated immune cell recruitment by: 1\. Physically regulating the interaction between endothelial and immune cells, that is required for recruitment into the inflamed brain. 2\. Containing proteoglycans that can directly act as chemokine receptors to drive immune cell recruitment during pathological neuroinflammation. This proposal will transform our understanding of how the glycocalyx regulates cell trafficking to the inflamed brain, using stroke as a model condition, which is the second leading cause of disability and death worldwide, but lacks treatment options.

View the original record at the funder ↗

Researchers

Douglas Dyer (EPMC Awardee)

Related Research

Grants with similar aims, by meaning.

Extracellular matrix mediated control of immune cell recruitment and positioning in health and disease
G-protein receptor signalling in CNS endothelial cells and its role in supporting lymphocyte migration
Molecular mechanisms retaining macrophages at sites of inflammation
Integrin-mediated regulation of NK cell motility and function
Regulation of microglial proliferation and its contribution to chronic neurodegeneration

Original classification

Career Development Award

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.